GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 11, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
3OF6 | Q6ISU1 | Human pre-T cell receptor crystal structure | |
7UAB | Q16819 | Human pro-meprin alpha (zymogen state) | |
7UAC | Q16819 | Human pro-meprin alpha (zymogen state) | |
2BOA | Q9UI42 | Human procarboxypeptidase A4. | |
2BOA | 2BOA | Human procarboxypeptidase A4. | |
2BOA | Q9UI42 | Human procarboxypeptidase A4. | |
2BOA | 2BOA | Human procarboxypeptidase A4. | |
1S63 | P49354 | Human protein farnesyltransferase complexed with L-778,123 and FPP | |
1S63 | P49356 | Human protein farnesyltransferase complexed with L-778,123 and FPP | |
6VG4 | Q9P2E7 | Human protocadherin 10 ectodomain | |
5MGS | Q12918 | Human receptor NKR-P1 in deglycosylated form, extracellular domain | |
5MGR | Q12918 | Human receptor NKR-P1 in glycosylated form, extracellular domain | |
7JIK | P02749 | Human recombinant Beta-2-Glycoprotein 1 | |
3VSX | P00797 | Human renin in complex with compound 18 | |
3VUC | P00797 | Human renin in complex with compound 5 | |
3VSW | P00797 | Human renin in complex with compound 8 | |
7XGK | P00797 | Human renin in complex with compound1 | |
7XGO | P00797 | Human renin in complex with compound2 | |
7XGP | P00797 | Human renin in complex with compound3 | |
3VYD | P00797 | Human renin in complex with inhibitor 6 | |
3VYE | P00797 | Human renin in complex with inhibitor 7 | |
3VYF | P00797 | Human renin in complex with inhibitor 9 | |
8BL8 | P46098 | Human serotonin 5-HT3A receptor (apo, active/distorted conformation) | |
8AXD | P46098 | Human serotonin 5-HT3A receptor (apo, resting conformation) | |
8BLA | P46098 | Human serotonin 5-HT3A receptor in complex with vortioxetine (detergent, ECD only, active/distorted conformation) | |
8BLB | P46098 | Human serotonin 5-HT3A receptor in complex with vortioxetine (nanodiscs, ECD, active/distorted conformation) | |
6M5E | P02768 | Human serum albumin with cyclic peptide dalbavancin | |
6M5E | 6M5E | Human serum albumin with cyclic peptide dalbavancin | |
4NC5 | Q9Y3R4 | Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate) | |
4NCS | Q9Y3R4 | Human sialidase 2 in complex with 2,3-difluorosialic acid (covalent intermediate) | |
8JEW | Q9UHI7 | Human sodium-dependent vitamin C transporter 1 bound to L-ascorbic acid in an inward-open state | |
8JEZ | Q9UHI7 | Human sodium-dependent vitamin C transporter 1 in an apo inward-open state | |
8JF1 | Q9UHI7 | Human sodium-dependent vitamin C transporter 1 in an apo occluded state | |
2IUL | P22966 | Human tACE g13 mutant | |
2IUX | P22966 | Human tACE mutant g1234 | ANGIOTENSIN-CONVERTING ENZYME (E.C.3.2.1.-, 3.4.15.1) |
4BZR | P12821 | Human testis angiotensin converting enzyme in complex with K-26 | |
4AYV | P00734 | Human thrombin - inhibitor complex | |
4AYV | P28508 | Human thrombin - inhibitor complex | |
4AYY | P00734 | Human thrombin - inhibitor complex | |
4AYY | P28506 | Human thrombin - inhibitor complex | |
4AZ2 | P00734 | Human thrombin - inhibitor complex | |
4AZ2 | P28509 | Human thrombin - inhibitor complex | |
2OD3 | P00734 | Human thrombin chimera with human residues 184a, 186, 186a, 186b, 186c and 222 replaced by murine thrombin equivalents. | |
3U8T | P00734 | Human thrombin complexed with D-Phe-Pro-D-Arg-Cys | |
3U8T | 3U8T | Human thrombin complexed with D-Phe-Pro-D-Arg-Cys | |
3U8O | P00734 | Human thrombin complexed with D-Phe-Pro-D-Arg-D-Thr | |
3U8O | 3U8O | Human thrombin complexed with D-Phe-Pro-D-Arg-D-Thr | |
3U8R | P00734 | Human thrombin complexed with D-Phe-Pro-D-Arg-Ile | |
3U8R | 3U8R | Human thrombin complexed with D-Phe-Pro-D-Arg-Ile | |
4AX9 | P00734 | Human thrombin complexed with Napsagatran, RO0466240 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024